INcreased Sun Exposure Without Pain In Research Participants With EPP or XLP

NCT06144840 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

165

Enrollment

INDUSTRY

Sponsor class

Conditions

Erythropoietic Protoporphyria (EPP)
X-Linked Protoporphyria (XLP)

Interventions

DRUG: Dersimelagon
DRUG: Placebo

Sponsor

Tanabe Pharma America, Inc.